A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (6) , 736-741
- https://doi.org/10.1016/s0959-8049(00)00008-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.Journal of Clinical Oncology, 1998
- Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinomaCancer Chemotherapy and Pharmacology, 1996
- A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinomaCancer, 1994
- Chemotherapy with Cisplatin and Continuous Infusion of 5-Fluorouracil and Bleomycin for Recurrent and Metastatic Nasopharyngeal Carcinoma in TaiwanOncology, 1993
- Phase II Study of High-Dose Ifosfamide as a Single Agent and in Combination with Cisplatin in the Treatment of Advanced and/or Recurrent Squamous Cell Carcinoma of Head and NeckOncology, 1993
- Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the princess margaret hospital experienceCancer, 1991
- Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.Journal of Clinical Oncology, 1991
- Phase II trial of ifosfamide in recurrent and metastatic head and neck cancerAnnals of Oncology, 1991
- Ifosfamide and Mesna for the Treatment of Advanced Squamous Cell Head and Neck CancerOncology, 1991
- Chemotherapy for nasopharyngeal carcinoma a ten-year experienceCancer, 1983